Sabra Health Care REIT sets up $750 million at-the-market stock sale program
Sabra Health Care REIT entered an equity distribution agreement allowing it to sell up to $750.0 million of common stock through agents and forward sale agreements, replacing a prior $500.0 million program from February 2023. The company intends to use net proceeds to repay debt, fund possible future investments and for general corporate purposes, which could dilute existing shareholders if shares are issued.
Key points
- New at-the-market program covers up to $750.0 million in gross offering price, with agent compensation up to $11.25 million.
- Prior 2023 program of $500.0 million was terminated on August 5, 2025; $109.3 million of unsold shares and $266.5 million under outstanding forward sale agreements remain.
- Forward sale agreements can be settled within one year; the company may settle in shares, cash or net shares, and it will receive no proceeds from forward shares until settlement.
The filing
Written by AI on Nov 8, 2026, 1:05 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 05, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.